One of America's top-selling EVs struggles in Australia, but the 2026 Ford Mustang Mach-E facelift ushers in welcome changes, including improved suspension, more range and better value. Plus, as the ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...